Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective
- Author
- BADER, P1 ; KREYENBERG, H1 ; GRUHN, B7 ; LANG, P1 ; GREIL, J1 ; HANDGRETINGER, R8 ; NIETHAMMER, D1 ; KLINGEBIEL, T9 ; BECK, J. F10 ; HOELLE, W1 ; DUECKERS, G1 ; KREMENS, B2 ; DILLOO, D3 ; SYKORA, K-W4 ; NIEMEYER, C5 ; REINHARDT, D6 ; VORMOOR, J6
[1] University Children's Hospital, Tübingen, Germany
[2] University Children's Hospital, Essen, Germany
[3] University Children's Hospital, Duesseldorf, Germany
[4] Hannover Medical School, Chihlren's Hospital, Hannover, Germany
[5] University Children's Hospital, Freiburg, Germany
[6] University Children's Hospital, Münster, Germany
[7] University Children's Hospital, Jena, Germany
[8] St Jude Children's Research Hospital, Memphis, TN, United States
[9] University Children's Hospital, Frankfurt, Germany
[10] University Children's Hospital, Greifswald, Germany - Source
Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 8, pp 815-821, 7 p ; ref : 44 ref
- CODEN
- BMTRE9
- ISSN
- 0268-3369
- Scientific domain
- Medical oncology; Graft, transplantation; Hematology
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- AML adjuvant immunotherapy allogeneic stem cell transplantation childhood chimerism
- Keyword (fr)
- Adjuvant Aigu Cellule hématopoïétique Cellule souche Chimérisme Enfant Homogreffe Hématologie Immunothérapie Leucémie myéloblastique Mixte Prévention Risque élevé Traitement Greffe Homme Hémopathie maligne
- Keyword (en)
- Adjuvant Acute Hematopoietic cell Stem cell Chimerism Child Homograft Hematology Immunotherapy Acute myelocytic leukemia Mixed Prevention High risk Treatment Graft Human Malignant hemopathy
- Keyword (es)
- Coadyuvante Agudo Célula hematopoyética Célula primitiva Quimerismo Niño Homoinjerto Hematología Inmunoterapia Leucemia mieloblástica Mixto Prevención Riesgo alto Tratamiento Injerto Hombre Hemopatía maligna
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15625228
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/sj.bmt.1704444 
https://dx.doi.org/10.1038/sj.bmt.1704444
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1704444\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"815\";s:8:\"\u0000*\u0000epage\";s:3:\"821\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BADER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:13:\"KREYENBERG, H\";i:1;s:8:\"GRUHN, B\";i:2;s:7:\"LANG, P\";i:3;s:8:\"GREIL, J\";i:4;s:16:\"HANDGRETINGER, R\";i:5;s:13:\"NIETHAMMER, D\";i:6;s:13:\"KLINGEBIEL, T\";i:7;s:10:\"BECK, J. F\";i:8;s:9:\"HOELLE, W\";i:9;s:11:\"DUECKERS, G\";i:10;s:10:\"KREMENS, B\";i:11;s:9:\"DILLOO, D\";i:12;s:11:\"SYKORA, K-W\";i:13;s:11:\"NIEMEYER, C\";i:14;s:12:\"REINHARDT, D\";i:15;s:10:\"VORMOOR, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1704444\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"815\";s:8:\"\u0000*\u0000epage\";s:3:\"821\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BADER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:13:\"KREYENBERG, H\";i:1;s:8:\"GRUHN, B\";i:2;s:7:\"LANG, P\";i:3;s:8:\"GREIL, J\";i:4;s:16:\"HANDGRETINGER, R\";i:5;s:13:\"NIETHAMMER, D\";i:6;s:13:\"KLINGEBIEL, T\";i:7;s:10:\"BECK, J. F\";i:8;s:9:\"HOELLE, W\";i:9;s:11:\"DUECKERS, G\";i:10;s:10:\"KREMENS, B\";i:11;s:9:\"DILLOO, D\";i:12;s:11:\"SYKORA, K-W\";i:13;s:11:\"NIEMEYER, C\";i:14;s:12:\"REINHARDT, D\";i:15;s:10:\"VORMOOR, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1704444\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1704444\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"815\";s:8:\"\u0000*\u0000epage\";s:3:\"821\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BADER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:13:\"KREYENBERG, H\";i:1;s:8:\"GRUHN, B\";i:2;s:7:\"LANG, P\";i:3;s:8:\"GREIL, J\";i:4;s:16:\"HANDGRETINGER, R\";i:5;s:13:\"NIETHAMMER, D\";i:6;s:13:\"KLINGEBIEL, T\";i:7;s:10:\"BECK, J. F\";i:8;s:9:\"HOELLE, W\";i:9;s:11:\"DUECKERS, G\";i:10;s:10:\"KREMENS, B\";i:11;s:9:\"DILLOO, D\";i:12;s:11:\"SYKORA, K-W\";i:13;s:11:\"NIEMEYER, C\";i:14;s:12:\"REINHARDT, D\";i:15;s:10:\"VORMOOR, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1704444\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"815\";s:8:\"\u0000*\u0000epage\";s:3:\"821\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BADER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:13:\"KREYENBERG, H\";i:1;s:8:\"GRUHN, B\";i:2;s:7:\"LANG, P\";i:3;s:8:\"GREIL, J\";i:4;s:16:\"HANDGRETINGER, R\";i:5;s:13:\"NIETHAMMER, D\";i:6;s:13:\"KLINGEBIEL, T\";i:7;s:10:\"BECK, J. F\";i:8;s:9:\"HOELLE, W\";i:9;s:11:\"DUECKERS, G\";i:10;s:10:\"KREMENS, B\";i:11;s:9:\"DILLOO, D\";i:12;s:11:\"SYKORA, K-W\";i:13;s:11:\"NIEMEYER, C\";i:14;s:12:\"REINHARDT, D\";i:15;s:10:\"VORMOOR, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1704444\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"815\";s:8:\"\u0000*\u0000epage\";s:3:\"821\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"BADER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:13:\"KREYENBERG, H\";i:1;s:8:\"GRUHN, B\";i:2;s:7:\"LANG, P\";i:3;s:8:\"GREIL, J\";i:4;s:16:\"HANDGRETINGER, R\";i:5;s:13:\"NIETHAMMER, D\";i:6;s:13:\"KLINGEBIEL, T\";i:7;s:10:\"BECK, J. F\";i:8;s:9:\"HOELLE, W\";i:9;s:11:\"DUECKERS, G\";i:10;s:10:\"KREMENS, B\";i:11;s:9:\"DILLOO, D\";i:12;s:11:\"SYKORA, K-W\";i:13;s:11:\"NIEMEYER, C\";i:14;s:12:\"REINHARDT, D\";i:15;s:10:\"VORMOOR, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:193:\"Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
